遗传性痉挛性截瘫临床诊疗的研究进展
Advances in the Clinical Diagnosis and Treatment of Hereditary Spastic Paraplegia
DOI: 10.12677/ACM.2022.1291277, PDF,    国家自然科学基金支持
作者: 刘 颖, 陈术玲, 佘任艺, 江 伟*:重庆医科大学附属儿童医院康复科,儿童发育障碍教育部重点实验室,国家儿童健康与障碍临床研究中心,中国儿童发育与危重障碍国际科技合作基地,重庆市儿科重点实验室,重庆
关键词: 痉挛性截瘫遗传性基因诊断治疗Spastic Paraplegia Hereditary Genetic Diagnosis Treatment
摘要: 遗传性痉挛截瘫是一组累及皮质脊髓束的神经退行性疾病,具有高度临床及基因异质性,主要临床表现为双下肢痉挛及相关运动障碍,可合并周围神经障碍,智力语言障碍及癫痫等神经功能障碍表现。其发病机制复杂,遗传方式多样,早期诊断困难,目前无特效治疗方案且系慢性退行性病程,常合并骨关节、消化道等功能障碍,治疗效果不佳。本文主要对HSP临床诊断及鉴别诊断、分型和治疗进展进行阐述,以利于该病的早期诊断及规范长程、多学科诊疗管理。
Abstract: Objective: Hereditary spastic paraplegia is a group of neurodegenerative diseases involving the cor-ticospinal tract, with a high degree of clinical and genetic heterogeneity. The main clinical manifes-tations are spasticity of both lower extremities and movement disorders, which may be combined with peripheral nerve dysfunction, intellectual and language impairment and other neurological dysfunctions. Its pathogenesis is complicated and genetic patterns are diverse, thus early diagnosis is difficult. The specific therapeutic regimen is deficient and the therapeutic effect is dissatisfied, moreover due to that the disease is chronic degenerative course, and often combined with bone joints, digestive tract and other functional disorders. This article mainly expounds on the clinical diagnosis, differential diagnosis, classification and treatment progress of HSP to facilitate the early diagnosis of the disease and standardize long-term, multidisciplinary diagnosis and treatment management.
文章引用:刘颖, 陈术玲, 佘任艺, 江伟. 遗传性痉挛性截瘫临床诊疗的研究进展[J]. 临床医学进展, 2022, 12(9): 8850-8858. https://doi.org/10.12677/ACM.2022.1291277

参考文献

[1] de Souza, P.V.S., de Rezende Pinto, W.B.V., de Rezende Batistella, G.N., et al. (2017) Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks. Cerebellum, 16, 525-551. [Google Scholar] [CrossRef] [PubMed]
[2] Harding, A.-E. (1983) Classification of the Hereditary Ataxias and Paraplegias. The Lancet, 321, 1151-1155. [Google Scholar] [CrossRef
[3] Novarino, G, Fenstermaker, A.-G., Zaki, M.-S., et al. (2014) Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders. Science, 343, 506-511. [Google Scholar] [CrossRef] [PubMed]
[4] Coutinho, P., Ruano, L., Loureiro, J.-L., et al. (2013) He-reditary Ataxia and Spastic Paraplegia in Portugal: A Population-Based Prevalence Study. JAMA Neurology, 70, 746-755. [Google Scholar] [CrossRef] [PubMed]
[5] Meyyazhagan, A. and Orlacchio, A. (2022) Hereditary Spastic Paraplegia: An Update. International Journal of Molecular Sciences, 23, Article No. 1697. [Google Scholar] [CrossRef] [PubMed]
[6] Chelban, V., Tucci, A., Lynch, D.-S., et al. (2017) Truncating Muta-tions in SPAST Patients Are Associated with a High Rate of Psychiatric Comorbidities in Hereditary Spastic Paraplegia. Journal of Neurology, Neurosurgery and Psychiatry, 88, 681-687. [Google Scholar] [CrossRef] [PubMed]
[7] Murala, S., Nagarajan, E. and Bollu, P.-C. (2021) Hereditary Spas-tic Paraplegia. Neurological Sciences, 42, 883-894. [Google Scholar] [CrossRef] [PubMed]
[8] Omidvar, M., Erfanian, Torkamandi, S., Rezaei, S., et al. (2021) Genotype-Phenotype Associations in Hereditary Spastic Paraplegia: A Systematic Review and Meta-Analysis on 13,570 Patients. Journal of Neurology, 268, 2065-2082. [Google Scholar] [CrossRef] [PubMed]
[9] Synofzik, M. and Schule, R. (2017) Overcoming the Divide be-tween Ataxias and Spastic Paraplegias: Shared Phenotypes, Genes, and Pathways. Movement Disorders, 32, 332-345. [Google Scholar] [CrossRef] [PubMed]
[10] 曹丽荣, 赵澎, 蔡春泉. 遗传性痉挛性截瘫的研究进展[J]. 国际神经病学神经外科学杂志, 2018, 45(5): 524-528.
[11] Mohan, N., Qiang, L., Morfini, G., et al. (2021) Therapeutic Strate-gies for Mutant SPAST-Based Hereditary Spastic Paraplegia. Brain Sciences, 11, Article No. 1081. [Google Scholar] [CrossRef] [PubMed]
[12] Shribman, S., Reid, E., Crosby, A.-H., et al. (2019) Hereditary Spastic Paraplegia: From Diagnosis to Emerging Therapeutic Approaches. The Lancet Neurology, 18, 1136-1146. [Google Scholar] [CrossRef
[13] Ruano, L., Melo, C., Silva, M.-C., et al. (2014) The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies. Neuroepidemi-ology, 42, 174-183. [Google Scholar] [CrossRef] [PubMed]
[14] Scheuer, K.-H., Svenstrup, K., Jennum, P., et al. (2007) Double-Blind Crossover Trial of Gabapentin in SPG4-Linked Hereditary Spastic Paraplegia. European Journal of Neurology, 14, 663-666. [Google Scholar] [CrossRef] [PubMed]
[15] Pointon, R., Whelan, H., Raza, R., et al. (2022) The Use of Intrathecal Baclofen for Management of Spasticity in Hereditary Spastic Paraparesis: A Case Series. European Journal of Paediatric Neurology, 36, 14-18. [Google Scholar] [CrossRef] [PubMed]
[16] Margetis, K., Korfias, S., Boutos, N., et al. (2014) Intrathecal Bac-lofen Therapy for the Symptomatic Treatment of Hereditary Spastic Paraplegia. Clinical Neurology and Neurosurgery, 123, 142-145. [Google Scholar] [CrossRef] [PubMed]
[17] de Niet, M., de Bot, S.-T., van de Warrenburg, B.-P., et al. (2015) Functional Effects of Botulinum Toxin Type-A Treatment and Subsequent Stretching of Spastic Calf Muscles: A Study in Patients with Hereditary Spastic Paraplegia. Journal of Rehabilitation Medicine, 47, 147-153. [Google Scholar] [CrossRef] [PubMed]
[18] 詹飞霞, 曹立. 常染色体显性遗传性痉挛性截瘫遗传学进展[J]. 上海交通大学学报(医学版), 2017, 37(11): 1552-1556.
[19] Bertolucci, F., Di Martino, S., Orsucci, D., et al. (2015) Robotic Gait Training Improves Motor Skills and Quality of Life in Hereditary Spastic Paraplegia. NeuroRehabilitation, 36, 93-99. [Google Scholar] [CrossRef
[20] 袁晓思, 赵江莉, 丁明晖, 等. 采用以骨盆控制训练为主康复治疗的遗传性痉挛性截瘫一例并文献复习(附视频二维码) [J]. 新医学, 2021, 52(1): 43-49.
[21] Ardolino, G., Bocci, T., Nigro, M., et al. (2021) Spinal Direct Current Stimulation (tsDCS) in Hereditary Spastic Paraplegias (HSP): A Sham-Controlled Crossover Study. The Journal of Spinal Cord Medicine, 44, 46-53. [Google Scholar] [CrossRef] [PubMed]
[22] Coelho, D.-B., Campos, D.D.S.F., et al. (2021) Spinal Cord Stimulation Improves Motor Function and Gait in Spastic Paraplegia Type 4 (SPG4): Clinical and Neurophysiological Evaluation. Parkinsonism and Related Disorders, 83, 1-5.
[23] 杨宇琦, 刘丽旭, 胡雪艳, 等. 中西医结合疗法对遗传性痉挛性截瘫的预后[J]. 川北医学院学报, 2021, 36(1): 87-90.
[24] Zhang, Y., Roxburgh, R., Huang, L., et al. (2014) The Effect of Hydrotherapy Treatment on Gait Characteristics of Hereditary Spastic Paraparesis Patients. Gait Posture, 39, 1074-1079. [Google Scholar] [CrossRef] [PubMed]
[25] Kerstens, H.C.J.W., Van Lith, B.J.H., Nijkrake, M.-J., et al. (2021) Healthcare Needs, Expectations, Utilization, and Experienced Treatment Effects in Patients with Hereditary Spastic Paraplegia: A Web-Based Survey in the Netherlands. Orphanet Journal of Rare Diseases, 16, Article No. 283. [Google Scholar] [CrossRef] [PubMed]
[26] 徐金山, 方铁, 梁树立, 等. 选择性脊神经后根切断术治疗遗传性痉挛性截瘫4例报告并文献复习[J]. 临床神经外科杂志, 2020, 17(2): 192-195.
[27] Bellofatto, M., De Michele, G., Iovino, A., et al. (2019) Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature. Frontiers in Neurology, 10, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
[28] Kai, M., et al. (2014) Long-Term Results of Selective Dorsal Rhi-zotomy for Hereditary Spastic Paraparesis. Journal of Clinical Neuroscience, 21, 116-120. [Google Scholar] [CrossRef] [PubMed]
[29] Fink, J.-K. (2013) Hereditary Spastic Paraplegia: Clini-co-Pathologic Features and Emerging Molecular Mechanisms. Acta Neuropathologica, 126, 307-328. [Google Scholar] [CrossRef] [PubMed]
[30] 雷旭露. 小针刀治疗单纯型遗传性痉挛性截瘫1例[C]//第十四届全国针灸经络学术研讨会暨针灸医学由基础到临床的转化学术交流会论文集. 深圳: 中国针灸学会, 2014: 143-145.
[31] 杨华强, 王云甫, 李东升, 等. 脐带间充质干细胞移植治疗遗传性痉挛性截瘫2例[J]. 中国组织工程研究与临床康复, 2011, 15(1): 167-170.
[32] 刘刚强, 靖明, 孟阳, 等. 脐带血间充质干细胞移植治疗遗传性痉挛性截瘫2例[J]. 武警后勤学院学报(医学版), 2013, 22(6): 544-546.
[33] 庞磊, 邵晋凯, 问晓东, 等. 遗传性痉挛性截瘫患者的泌尿系统功能障碍及尿动力学研究结果[J]. 中国药物与临床, 2019, 19(18): 3160-3162.